Literature DB >> 28474235

Patients treated with immunosuppressive steroids are less aware of sick day rules Than those on endocrine replacement therapy and may be at greater risk of adrenal crisis.

M R Salehmohamed1, M Griffin2, T Branigan2, M Cuesta1, C J Thompson3.   

Abstract

BACKGROUND: Patients taking corticosteroids for immune suppression are vulnerable to adrenal crisis during acute illness or if steroids are stopped abruptly. Although patients treated for adrenal failure in endocrine units are routinely provided with sick day guidelines, we wished to ascertain whether patients on immunosuppressive steroids are appropriately advised. AIM: This study sets out to compare patient awareness of steroid sick day rules in endocrine and non-endocrine patients.
DESIGN: A short case history is presented to illustrate the clinical impact of adrenal crisis in a patient on immune suppression. Subsequently, we present the results of a 9-point questionnaire, devised to determine knowledge of steroid sick day rules, in two patient cohorts. In group 1, patients on immunosuppressive steroids were recruited from non-endocrine clinics to complete the questionnaire. In group 2, patients on replacement steroids were recruited from endocrine clinics.
RESULTS: Endocrine patients exhibited better steroid use awareness; they were more likely to double their steroid dose when ill (89 v/s 23%), to obtain parenteral steroid during vomiting (83 v/s 27%), or during surgery (87 v/s 30%), and were aware of the need to carry a MedicAlert bracelet or a steroid-aware card (82 v/s 21%), (p < 0.001 for all comparisons).
CONCLUSION: Endocrine patients exhibited a significantly greater knowledge of sick day rules. The data does highlight the lack of patient awareness of the precautions for steroid use in patients on immunosuppressive steroid therapy for non-endocrine conditions, and the case presentation illustrates the potential hazards of this lack of awareness.

Entities:  

Keywords:  Adrenal crisis; Cortisol deficiency; Glucocorticoid education

Mesh:

Substances:

Year:  2017        PMID: 28474235     DOI: 10.1007/s11845-017-1607-y

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  18 in total

1.  The contribution of undiagnosed adrenal insufficiency to euvolaemic hyponatraemia: results of a large prospective single-centre study.

Authors:  Martín Cuesta; Aoife Garrahy; David Slattery; Saket Gupta; Anne Marie Hannon; Hannah Forde; Karen McGurren; Mark Sherlock; William Tormey; Christopher J Thompson
Journal:  Clin Endocrinol (Oxf)       Date:  2016-07-12       Impact factor: 3.478

2.  Steroid cards: patient compliance.

Authors:  W W Downie; P A Leatham; V M Rhind; V Wright
Journal:  Br Med J       Date:  1977-02-12

3.  Use of steroid cards by patients with respiratory disease.

Authors:  A J Johnson
Journal:  Thorax       Date:  1979-04       Impact factor: 9.139

4.  Prevention of corticosteroid induced osteoporosis in inpatients recently discharged from a tertiary teaching hospital.

Authors:  M D Smith; S P Cheah; K Taylor; M J Ahern
Journal:  J Rheumatol       Date:  2001-03       Impact factor: 4.666

5.  Glucocorticoid replacement therapy in adrenal insufficiency--a challenge to physicians?

Authors:  Birgit Harbeck; Swantje Brede; Claudia Witt; Sven Süfke; Hendrik Lehnert; Christian Haas
Journal:  Endocr J       Date:  2015-02-26       Impact factor: 2.349

6.  High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study.

Authors:  Stefanie Hahner; Christina Spinnler; Martin Fassnacht; Stephanie Burger-Stritt; Katharina Lang; Danijela Milovanovic; Felix Beuschlein; Holger S Willenberg; Marcus Quinkler; Bruno Allolio
Journal:  J Clin Endocrinol Metab       Date:  2014-11-24       Impact factor: 5.958

7.  Corticosteroid therapy and intercurrent illness: the need for continuing patient education.

Authors:  S R Peacey; R M Pope; K S Naik; R D Hardern; M D Page; P E Belchetz
Journal:  Postgrad Med J       Date:  1993-04       Impact factor: 2.401

8.  Pituitary-adrenal function after prolonged glucocorticoid therapy for systemic inflammatory disorders: an observational study.

Authors:  K Sacre; M Dehoux; M P Chauveheid; M Chauchard; O Lidove; R Roussel; T Papo
Journal:  J Clin Endocrinol Metab       Date:  2013-06-12       Impact factor: 5.958

9.  A glucocorticoid education group meeting: an effective strategy for improving self-management to prevent adrenal crisis.

Authors:  Han J W J Repping-Wuts; Nike M M L Stikkelbroeck; Alida Noordzij; Mies Kerstens; Ad R M M Hermus
Journal:  Eur J Endocrinol       Date:  2013-05-17       Impact factor: 6.664

10.  Adrenal suppression in patients taking inhaled glucocorticoids is highly prevalent and management can be guided by morning cortisol.

Authors:  Conor P Woods; Nicola Argese; Matthew Chapman; Christopher Boot; Rachel Webster; Vijay Dabhi; Ashley B Grossman; Andrew A Toogood; Wiebke Arlt; Paul M Stewart; Rachel K Crowley; Jeremy W Tomlinson
Journal:  Eur J Endocrinol       Date:  2015-08-20       Impact factor: 6.664

View more
  1 in total

1.  Variability in counselling for adrenal insufficiency in COVID-19 and beyond: a survey of rheumatology practice.

Authors:  Puja Mehta; Karim Meeran; Elizabeth Macphie; Afroze Abbas; Jonathan Rippin; Rachel C Jeffery; Venkat Reddy; Maria J Leandro; Coziana Ciurtin; Helen L Simpson; Sarah L Mackie
Journal:  Lancet Rheumatol       Date:  2020-12-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.